Newsroom

Newsroom

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

Press Release
Read More

Taking the STING out of Oncology

Blog
Read More

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

Press Release
Read More

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Press Release
Read More

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Press Release
Read More

DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma

Literature
Read More

NeoGenomics Reports Second Quarter 2024 Results

Press Release
Read More

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients